Call for papers
Call for papers
Focus & Aim:
Nano Materials and Nano Drugs (NMND) is dedicated to advancing the application of nanotechnology in the field of nanomedicine. Nanotechnology-based medicine sciences have brought new selections for preventing, diagnosing, monitoring, and treating various diseases. More novel technology, methods, tools, materials are likely to emerge. NMND is such a platform for researchers to exchange scientific information. This open access journal targets a wide range of audience from scholars, industrial investigators, and clinical researchers, to relevant companies in this field.
Article formats of this journal are original research articles, review articles, editorials, case reports, perspectives, letters and commentaries.
The scope of NMND includes but is not limited to:
- Nanomaterials for use in nanomedicine: nanoparticles, liposomes, and dendrimers
- Nano-drug delivery systems
- Nano-drug carriers
- Nano-drug based nanoprobe
- Tissue engineering
- Nanomedical tools
- Bio-sensors
- Imaging
- Synthesis and characterization of medical nanomaterials
Journal Sponsorship
Nano Materials and Nano Drugs (NMND) is published by Academic Publishing Pte. Ltd., and financially supported by Asia Pacific Academy of Science Pte. Ltd.
Whioce Publishing Pte. Ltd. and EnPress Publisher LLC. provide the technological guidance, who have rich publishing experience of high quality journals. International Journal of Bioprinting (eISSN: 2424-8002; ISSN: 2424-7723) published by Whioce Publishing Pte. Ltd. has been indexed by SCIE and Scopus. Journal of Infrastructure, Policy and Development (eISSN: 2572-7931, ISSN: 2572-7923) published by EnPress Publisher LLC. has been indexed by ESCI and Scopus. Trends in Immunotherapy (eISSN: 2573-5985) published by EnPress Publisher LLC. has been indexed by Scopus.
Article Processing Charges
Nano Materials and Nano Drugs (NMND) receives financial support from Asia Pacific Academy of Science Pte. Ltd., hence the APC is free for authors for the time being. The editorial office of NMND expresses its sincere thanks to the sponsor.
Statement of Clarification
We would also like to clarify that our editorial decisions in submissions, selection of editorial board members, and integrity of articles are not affected by the affiliated commercial entities.
Submissions
Please refer to the Author Guides for format related requirements.
Online submissions: http://ojs.acad-pub.com/index.php/nmnd/about/submissions#onlineSubmissionss
Or please feel free to contact us: editorial-nmnd@acad-pub.com
More information, please visit the website: http://ojs.acad-pub.com/index.php/nmnd/index
E-mail: editorial-nmnd@acad-pub.com
Editorial Office of Nano Materials and Nano Drugs (NMND)